Dogwood Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks

$3.17

+0.00 (+0.00%)

As of Feb 8, 2:11 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +596.5% upside

Low Target $13.69

Average Target $22.08

High Target $22.84

Current Price $3.17

Current
$3.17

Target
$22.08

$13.69 $22.08 avg $22.84

Scenario Analysis

Bear Case

$13.69

331.9%

Low target

Base Case

$22.08

+596.5%

Avg target

Bull Case

$22.84

+620.5%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$25.53

-87.6% from high

52-Week Low

$10.98

+-71.1% from low

Target vs 52W High

$22.08

-13.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%